DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Riociguat Oral Product ( DrugBank:
Riociguat
)
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
86
肺動脈性肺高血圧症
1
86. 肺動脈性肺高血圧症
臨床試験数
:
1,205
/
薬物数
:
684
- (
DrugBank
:
124
) /
標的遺伝子数
:
100
-
標的パスウェイ数
:
193
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT03809156
(
ClinicalTrials.gov
)
April 26, 2016
9/1/2019
Upfront Combination Pulmonary Arterial Hypertension Therapy
Upfront Riociguat and Ambrisentan Combination Therapy for Pulmonary Arterial Hypertension: A Safety and Efficacy Pilot Study
Upfront Riociguat and Ambrisentan Combination Therapy for Pulmonary Arterial Hypertension: A Safety ...
Pulmonary Hypertension
Drug:
Riociguat Oral Product
University of Calgary
Bayer
Recruiting
18 Years
N/A
All
20
Phase 4
Canada